DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Income | ₹2,461 Cr | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr |
What is the latest Revenue of DR LAL PATHLABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,461 Cr |
| Mar2025 | ₹2,227 Cr |
| Mar2024 | ₹2,017 Cr |
| Mar2023 | ₹2,087 Cr |
| Mar2022 | ₹1,581 Cr |
How is Revenue of DR LAL PATHLABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,461 Cr | 10.54 | |
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | - | |
Compare Revenue of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹31,940.7 Cr | -1.7% | 0.4% | 17.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹125,998.0 Cr | -0.3% | -0.7% | 13.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,008.9 Cr | -0.5% | -7.6% | -13.8% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹68,769.1 Cr | -0.8% | -3.5% | -0.9% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹66,090.2 Cr | -0.5% | -6.8% | 25.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,605.1 Cr | 2.9% | 1% | 7.2% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -1.7% |
0.4% |
17.3% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses